Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis
E Castillero, H Akashi, M Najjar, R Ji… - American Journal …, 2020 - journals.physiology.org
Myostatin (MSTN) is a transforming growth factor (TGF)-β superfamily member that acts as a
negative regulator of muscle growth and may play a role in cardiac remodeling. We …
negative regulator of muscle growth and may play a role in cardiac remodeling. We …
Activin Type II Receptor Ligand Signaling Inhibition After Experimental Ischemic Heart 1 Failure Attenuates Cardiac Remodeling and Prevents Fibrosis 2
E Castilleroa, H Akashia, M Najjara, R Jib… - journals.physiology.org
1 Activin Type II Receptor Ligand Signaling Inhibition After Experimental Ischemic Heart 1
Failure Attenuates Cardiac Remodeling Page 1 1 Activin Type II Receptor Ligand Signaling …
Failure Attenuates Cardiac Remodeling Page 1 1 Activin Type II Receptor Ligand Signaling …
[PDF][PDF] Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis
XE Castillero, H Akashi, M Najjar, R Ji… - Am J Physiol Heart …, 2020 - academia.edu
Myostatin (MSTN), also known as growth differentiation factor-8 (GDF8), is a signaling
protein from the transforming growth factor (TGF)-superfamily that acts as one of the few …
protein from the transforming growth factor (TGF)-superfamily that acts as one of the few …
Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis
E Castillero, H Akashi, M Najjar, R Ji… - American journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Myostatin (MSTN) is a transforming growth factor (TGF)-β superfamily member that acts as a
negative regulator of muscle growth and may play a role in cardiac remodeling. We …
negative regulator of muscle growth and may play a role in cardiac remodeling. We …
Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
E Castillero, H Akashi, M Najjar, R Ji… - American Journal of …, 2019 - europepmc.org
Myostatin (MSTN) is a transforming growth factor (TGF)-β superfamily member that acts as a
negative regulator of muscle growth and may play a role in cardiac remodeling. We …
negative regulator of muscle growth and may play a role in cardiac remodeling. We …
Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
E Castillero, H Akashi, M Najjar, R Ji… - American Journal of …, 2019 - europepmc.org
Myostatin (MSTN) is a transforming growth factor (TGF)-β superfamily member that acts as a
negative regulator of muscle growth and may play a role in cardiac remodeling. We …
negative regulator of muscle growth and may play a role in cardiac remodeling. We …